Recurrent urinary tract infections: evidence base and debatable issues in non-antibacterial prevention
DOI:
https://doi.org/10.22141/2307-1257.9.4.2020.218238Keywords:
recurrent urinary tract infections, women, forinalAbstract
Recurrent urinary tract infection (UTI) is a highly prevalent, costly, and burdensome condition affecting women of all ages, races, and ethnicities without regard for socioeconomic status, or educational level. Modern strategies aimed at preventing recurrent UTI are still not optimal, as evidenced by the relatively high prevalence of this nosology in women. The purpose of this article was to highlight and discuss both the evidence base and a number of unresolved issues in the management of recurrent UTI. The following topics of clinical interest are considered: diagnosis, age-related associations, continuous and intermittent antimicrobial prophylaxis, the effectiveness of modern non-antimicrobial prophylaxis, the potential role of forinal (a complex of D-mannose and cranberry fruit extract) in the prevention of recurrent UTI.Downloads
References
Bonkat G, Bartoletti R, Bruyere F, et al. Urological Infections: EAU Guidelines 2020. Available from: https://uroweb.org/guideline/urological-infections/.
National Institute for Health and Care Excellence (NICE). Urinary tract infection (recurrent): antimicrobial prescribing: NICE guideline [NG112]. Available from: https://www.nice.org.uk/guidance/ng112. Accessed: October 31, 2018.
Perepanova TS, Kozlov RS, Rudnov VA, Siniakova LA, Palagin IS. Antimikrobnaia terapiia i profilaktika infektsii pochek, mochevyvodiashchikh putei i muzhskikh polovykh organov: Federal'nye klinicheskie rekomendatsii [Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and male genital organs]. Moscow; 2020. 63 р. (in Russian).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 S.O. Vozianov, D.D. Ivanov, S.V. Kushnirenko, O.O. Shevchuk, V.O. Mazurets, O.V. Kushnirenko

This work is licensed under a Creative Commons Attribution 4.0 International License.